Clinical trials have shown that vildagliptin is effective in significantly lowering glycosylated hemoglobin (HbA 1c), fasting plasma glucose, and prandial glucose levels. Beta-cell function may ...

Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...

Type 2 diabetes and obesity are intimately linked; reduction of bodyweight improves glycemic control, mortality and morbidity. Treating obesity in the diabetic is hampered as some diabetic ...